Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin.
Moppett
J
J
van der Velden
V H J
VH
Wijkhuijs
A J M
AJ
Hancock
J
J
van Dongen
J J M
JJ
Goulden
N
N
D000208:Acute Disease; D000818:Animals; D002417:Cattle; D004273:DNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D003937:Diagnosis, Differential; D015329:Gene Rearrangement, T-Lymphocyte / Q000235:genetics*; D005803:Genes, Immunoglobulin / Q000235:genetics; D019672:Genes, T-Cell Receptor / Q000235:genetics; D006801:Humans; D007945:Leukemia, Lymphoid / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D016133:Polymerase Chain Reaction / Q000187:drug effects* / Q000379:methods*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology; D012015:Reference Standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012710:Serum Albumin, Bovine / Q000235:genetics / Q000378:metabolism*
D004273:DNA, Neoplasm; D012710:Serum Albumin, Bovine